BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,350.00
+5.00 (0.15%)
At close: Jun 27, 2025, 3:30 PM KST
-28.80%
Market Cap 27.24B
Revenue (ttm) 14.13B
Net Income (ttm) -4.13B
Shares Out 8.18M
EPS (ttm) -504.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,275
Average Volume 10,902
Open 3,345.00
Previous Close 3,345.00
Day's Range 3,325.00 - 3,405.00
52-Week Range 2,750.00 - 4,835.00
Beta 1.12
RSI 52.48
Earnings Date Aug 14, 2025

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.